Background data
Program Type : Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Program Director
| Name |
Phone |
| Celalettin Ustun, MD |
(312) 942-5982 |
Medical Director
| Name |
Phone |
| Celalettin Ustun, MD |
(312) 942-5982 |
Physician
| Name |
Phone |
| Anmol Baranwal, MD |
(312) 942-5982 |
| Mouhammed Kelta, MD |
(312) 942-5982 |
| Patrick Moore, MD |
(312) 942-5982 |
| Sunita Nathan, MD |
(312) 942-5982 |
Coordinator
| Name |
Phone |
| Christina Carmignani, RN |
(312) 226-2371 |
| Karla Cavazos, RN |
(312) 942-1181 |
| Cory Fronza, RN |
(312) 942-5158 |
| Brenna Langan, RN |
(312) 226-2371 |
| Emilee Moeke, RN |
(312) 942-6028 |
| Allison Weis, BSN, RN, BMTCN |
(312) 226-2371 |
Social Worker
| Name |
Phone |
| Grace Mooney-Melvin, LCSW |
|
| Claire Tobin, MSW |
|
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)